About Us


Jeff Bedard


Jeff Bedard is the President/CEO of Crown Laboratories, Inc. Before founding Crown Laboratories, Inc. in 2000, Mr. Bedard held positions in sales and market development with Stiefel Laboratories, Inc. and Herald Pharmacal, Inc. Mr. Bedard owned a consulting firm, providing marketing and business development management advice for small to medium pharmaceutical companies.

Mr. Bedard has been a Director of Crown Laboratories, Inc. since 2000 and served previously as Chairman of the Board and President. Mr. Bedard currently serves on the Boards of Northeast Tennessee State Community College Foundation, ETSU Foundation and Mountain States Foundation. He recently was inducted in the Science Hill Sports Hall of Fame.

Mr. Bedard graduated with honors from University of Iowa with a degree in Chemistry.

Jack Songster

Chief Operations Officer

Jack Songster was named COO for Crown Laboratories, Inc. in October, 2014 and has been a Board Member of Crown Laboratories, Inc. since 2014. He joined Crown Laboratories in February 2012, assuming responsibility for all operations activities and served as the Vice President of Manufacturing and Site GM at Crown Laboratories’ facility in Johnson City, TN.

Previously, Mr. Songster was Senior Vice President of Manufacturing for Pfizer, Inc. and King Pharmaceuticals, where he held multi-site technical operations responsibility for two solid-dosage and semi-solids plants, a sterile manufacturing site and a chromatographic purification location. Mr. Songster’s wealth of manufacturing and logistics experience in the highly regulated medical device and pharmaceutical industry, totals more than 25 years.

Nick Crowe

Executive Vice President Global Finance

Mr. Crowe serves as Crown Laboratories’ Director of Finance. Prior to joining Crown, Mr. Crowe was the senior manager of the Consulting and Audit Departments at a Regional accounting firm, Blackburn, Childers and Steagall, PLC. While in public practice, Mr. Crowe specialized in manufacturing clients and medical practices. Mr. Crowe earned his bachelor’s degree in Business Administration with concentrations in both Accounting and Logistics and Transportation from the University of Tennessee. Mr. Crowe is a licensed Certified Public Accountant in the state of Tennessee.

Barry Mounts

Executive Vice President Global Human Resources

Mr. Mounts serves as Crown Laboratories’ Vice President of Human Resources. With over 18 years in Human Resources, he is a respected business and solutions-oriented HR executive. Over his many years of experience, Mr. Mounts has managed the Human Resources function at a senior level, in multiple arenas, including energy, manufacturing, healthcare and consulting. Previously, Mr. Mounts served as Vice President, Human Resources for Alpha Natural Resources. Mr. Mounts earned his Masters of Science, Human Resources Management degree at the University of Charleston, Charleston, WV and executive education from the University of Virginia, Darden School of Business.

Alyson Hogg, MBE

Chief Creative Officer

Alyson Hogg is the Founder and Creator of Vita Liberata

Ms. Hogg enjoyed a multi-faceted professional career, which spanned broadcasting, academia, hospitality and politics. She was Communications Director of the Women’s Coalition in Northern Ireland during the 1998 Peace Process, before creating Vita Liberata in 2003. Ms. Hogg has been the inspiration behind the Vita Liberata brand’s phenomenal success.  She joined Crown Laboratories in 2017 and has been a director since 2018.

Ms. Hogg completed her undergraduate studies in Philosophy and was researching her PhD in Philosophy of Psychology, when she decided to focus on business, instead. She holds the position of Distinguished Graduate at the University of Ulster and received the Queen’s Award for Industry in 2014 and 2015. She was awarded the MBE (Member of the Order of the British Empire) in the Queen’s Honours List in 2017.

Joe Proctor

President, Bellus Medical

Joe Proctor is President of Bellus Aesthetics and an award-winning inventor in aesthetics. He launched Bellus Medical in 2012 to help leading physician-directed practices around the world grow their businesses. The aesthetic division of Crown Laboratories since 2018, Bellus specializes in non-invasive innovations that act as “gateway” products to draw new patients to its partners.

Mr. Proctor began his career in aesthetics more than 15 years ago through progressive sales development and training. As a strong influencer in the industry, he leads by example by offering products of the highest quality and safety standards, and by providing best-in-class customer service and education. He is the winner of the Non-Physician Technology Innovator of the Year from The Aesthetic Show with Bellus as the winner of multiple Aesthetic Everything Awards and the SkinPen® microneedling device as the winner of the United Kingdom-based Barry Knapp Award for Product Innovation of the Year.

Thomas Hitchcock, Ph.D.

Chief Science Officer

Dr. Hitchcock serves as the Chief Science Officer for Crown Laboratories and oversees the Clinical Development, Medical Affairs and Research & Development for Crown and its subsidiaries. He is also the Founder of Xycrobe Therapeutics Inc. (http://www.xycrobe.com) and serves as its Chief Executive Officer. Additionally, Dr. Hitchcock served as the Acting Chief Scientific Officer and Vice President of Clinical & Medical Affairs at Bellus Medical from its inception in 2013 up to the acquisition by Crown Laboratories.

Previous to his work in the industry, Dr. Hitchcock performed research at Weill Cornell Medical College where he studied multiple myeloma genetics. He also performed his Post-doctoral Research in tissue engineering and regenerative medicine at Duke University and Yale University. Following his post-doctoral studies, Dr. Hitchcock began working in the field of dermatology at companies like Suneva Medical and Ulthera, as well as consultancy for companies such as Boehringer Ingelheim and Bayer. 

Dr. Hitchcock has more than 15 years of research experience including Basic Science, Proof-of-Concept, Pre-Clinical and Clinical Research across several therapeutic areas such as Cardiology, Oncology, Gene Therapy, Plastic/Facial plastic surgery, Dermatology and Aesthetic medicine. Dr. Hitchcock earned his Ph.D. in Genetics from Clemson University and completed postdoctoral trainings at Duke University and Yale University in Biomedical Engineering, Vascular Biology and Therapeutics.